Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Carl Van Laer"'
Autor:
Frederik Soffers, Nils Helsen, Tim Van den Wyngaert, Laurens Carp, Otto S. Hoekstra, Laurence Goethals, Michel Martens, Kristof Deben, Karoline Spaepen, Remco De Bree, Frank De Geeter, G. J. C. Zwezerijnen, Carl Van Laer, Alex Maes, Olivier Lenssen, Sigrid Stroobants, the ECLYPS Investigators
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Background FDG-PET/CT has a high negative predictive value to detect residual nodal disease in patients with locally advanced squamous cell head and neck cancer after completing concurrent chemoradiotherapy (CCRT). However, the positive pred
Externí odkaz:
https://doaj.org/article/e9ba60f4f41e45a5a02c65b9b2f9bdd9
Autor:
Margot Baudelet, Leen Van den Steen, Fréderic Duprez, Marc De Bodt, Sarah Deschuymer, Ann Goeleven, Isabel Hutsebaut, Steven Mariën, Sabine Meersschout, Daan Nevens, Sandra Nuyts, Marc Peeters, Pol Specenier, Michiel Van den Brekel, Lisette van der Molen, Caroline Vandenbruaene, Olivier Vanderveken, Joost Van Dinther, Carl Van Laer, Tom Vauterin, Hilde Verstraete, Gwen Van Nuffelen, Member of the Belgian PRESTO Group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background Dysphagia is a common and serious complication after (chemo)radiotherapy (CRT) for head-and-neck cancer (HNC) patients. Prophylactic swallowing exercises (PSE) can have a significantly positive effect on post-treatment swallowing
Externí odkaz:
https://doaj.org/article/1196c6d666b74d689ea0b6a6a4e0ecf7
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The traditional concept of post-treatment surveillance in head and neck cancer patients relies on examinations directed at early detection of disease recurrence and/or second primary tumors. They are usually provided by ear, nose and throat specialis
Externí odkaz:
https://doaj.org/article/505e4332f95f44ada2ed4bed623877df
Autor:
Ann Goeleven, Sabine Meersschout, Olivier M. Vanderveken, Margot Baudelet, Isabel Hutsebaut, Carl Van Laer, Joost van Dinther, Pol Specenier, Marc Peeters, Sarah Deschuymer, Daan Nevens, Michiel W. M. van den Brekel, Sandra Nuyts, Lisette van der Molen, Caroline Vandenbruaene, F. Duprez, Tom Vauterin, Gwen Van Nuffelen, Hilde Verstraete, Steven Mariën, Leen Van den Steen, Marc De Bodt
Publikováno v:
Trials, 21:237. BioMed Central
Trials
Trials, 21(1):237. BioMed Central
TRIALS
Trials, Vol 21, Iss 1, Pp 1-10 (2020)
Trials
Trials, 21(1):237. BioMed Central
TRIALS
Trials, Vol 21, Iss 1, Pp 1-10 (2020)
Background Dysphagia is a common and serious complication after (chemo)radiotherapy (CRT) for head-and-neck cancer (HNC) patients. Prophylactic swallowing exercises (PSE) can have a significantly positive effect on post-treatment swallowing function.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2810c23e54bb30acc43b9fc2f9a1bf3
https://dare.uva.nl/personal/pure/en/publications/study-protocol-for-a-randomized-controlled-trial-prophylactic-swallowing-exercises-in-headandneck-cancer-patients-treated-with-chemoradiotherapy-presto-trial(3676bc90-517c-47bf-9750-f9e3b1da1e5d).html
https://dare.uva.nl/personal/pure/en/publications/study-protocol-for-a-randomized-controlled-trial-prophylactic-swallowing-exercises-in-headandneck-cancer-patients-treated-with-chemoradiotherapy-presto-trial(3676bc90-517c-47bf-9750-f9e3b1da1e5d).html
Autor:
Navin Mani, Frans Gordts, Callum Faris, Olivier M. Vanderveken, Gilles Van Haesendonck, Steven Mariën, Carl Van Laer, Roberto Puxeddu, Katia Verbruggen, Kristof Deben
Publikováno v:
B-ENT
The primary aim was to review the guidelines published by Otolaryngology Societies for performing tracheostomies in the COVID-19 pandemic. A secondary aim was to briefly review the literature for the effectiveness of surgical masks, N-95 and FFP-3 re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::545044dd2d22f19718f9cf3f937f374d
https://doi.org/10.5152/b-ent.2020.20128
https://doi.org/10.5152/b-ent.2020.20128
Autor:
Philip R. Debruyne, Maes A, Otto S. Hoekstra, Olivier Lenssen, M. Martens, Carl Van Laer, Isabel Hutsebaut, Remco de Bree, Nils Helsen, Laurens Carp, Eclyps investigators, Sabine Meersschout, Joost van Dinther, Danielle Van den Weyngaert, Tim Van den Wyngaert, Jan B. Vermorken, Sara Hakim, Sigrid Stroobants
Publikováno v:
Journal of Clinical Oncology, 35(30), 3458. American Society of Clinical Oncology
Journal of Clinical Oncology, 35(30), 3458-3464. American Society of Clinical Oncology
Journal of clinical oncology
Van Den Wyngaert, T, Helsen, N, Carp, L, Hakim, S, Martens, M J, Hutsebaut, I, Debruyne, P R, Maes, A L M, Van Dinther, J, Van Laer, C G, Hoekstra, O S, De Bree, R, Meersschout, S A E, Lenssen, O, Vermorken, J B, Van Den Weyngaert, D, Stroobants, S & ECLYPS investigators 2017, ' Fluorodeoxyglucose-positron emission tomography/computed tomography after concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer : The ECLYPS study ', Journal of Clinical Oncology, vol. 35, no. 30, pp. 3458-3464 . https://doi.org/10.1200/JCO.2017.73.5845
Journal of Clinical Oncology, 35(30), 3458-3464. American Society of Clinical Oncology
Journal of clinical oncology
Van Den Wyngaert, T, Helsen, N, Carp, L, Hakim, S, Martens, M J, Hutsebaut, I, Debruyne, P R, Maes, A L M, Van Dinther, J, Van Laer, C G, Hoekstra, O S, De Bree, R, Meersschout, S A E, Lenssen, O, Vermorken, J B, Van Den Weyngaert, D, Stroobants, S & ECLYPS investigators 2017, ' Fluorodeoxyglucose-positron emission tomography/computed tomography after concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer : The ECLYPS study ', Journal of Clinical Oncology, vol. 35, no. 30, pp. 3458-3464 . https://doi.org/10.1200/JCO.2017.73.5845
Purpose To assess the standardized implementation and reporting of surveillance [18F]fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) scan of the neck in locoregionally advanced head-and-neck squamous cell carcinoma (L
Autor:
Pol Specenier, Marco Benasso, Olivier M. Vanderveken, Jan B. Vermorken, Marco Merlano, Carl Van Laer, Dirk Van Gestel, Danielle Van den Weyngaert, Petr Szturz, Marc Peeters, Kristien Wouters
Publikováno v:
The oncologist
Platinum-based concurrent chemoradiation (CCRT) improves locoregional control and overall survival of locoregionally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) when compared to radiotherapy alone, but this approach is hampered
Autor:
Philip R. Debruyne, Remco de Bree, Otto S. Hoekstra, Sara Hakim, Oliver Lenssen, Pol Specenier, M. Martens, Laurence Beels, Filip Homans, Frank De Geeter, Laurence Goethals, Maes A, Carl Van Laer, Olivier M. Vanderveken, Joost Van Dinter, Karoline Spaepen, Alex Maes, Laurens Carp, Nils Helsen, Isabel Hutsebaut, Danielle Van den Weyngaert, Jean-Philippe Cambier, Kristof Deben, Sigrid Stroobants, Tim Van den Wyngaert
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 47(5), 1075-1082. Springer Verlag
European journal of nuclear medicine and molecular imaging
European Journal of Nuclear Medicine and Molecular Imaging, 47(5), 1075. Springer Verlag
Helsen, N, Van den Wyngaert, T, Carp, L, De Bree, R, VanderVeken, O M, De Geeter, F, Maes, A, Cambier, J-P, Spaepen, K, Martens, M, Hakim, S, Beels, L, Hoekstra, O S, Van den Weyngaert, D, Stroobants, S, Van Laer, C, Specenier, P, Maes, A, Debruyne, P, Hutsebaut, I, Van Dinter, J, Homans, F, Goethals, L, Lenssen, O, Deben, K & ECLYPS Consortium 2020, ' Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy : results from the ECLYPS study ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 5, pp. 1075-1082 . https://doi.org/10.1007/s00259-020-04710-4
European journal of nuclear medicine and molecular imaging
European Journal of Nuclear Medicine and Molecular Imaging, 47(5), 1075. Springer Verlag
Helsen, N, Van den Wyngaert, T, Carp, L, De Bree, R, VanderVeken, O M, De Geeter, F, Maes, A, Cambier, J-P, Spaepen, K, Martens, M, Hakim, S, Beels, L, Hoekstra, O S, Van den Weyngaert, D, Stroobants, S, Van Laer, C, Specenier, P, Maes, A, Debruyne, P, Hutsebaut, I, Van Dinter, J, Homans, F, Goethals, L, Lenssen, O, Deben, K & ECLYPS Consortium 2020, ' Quantification of 18F-fluorodeoxyglucose uptake to detect residual nodal disease in locally advanced head and neck squamous cell carcinoma after chemoradiotherapy : results from the ECLYPS study ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 5, pp. 1075-1082 . https://doi.org/10.1007/s00259-020-04710-4
BACKGROUND: The Hopkins criteria were introduced for nodal response evaluation after therapy in head and neck cancer, but its superiority over quantification is not yet confirmed.METHODS: SUVbody weight thresholds and lesion-to-background ratios were
Autor:
Cathy L. Lazarus, Sophie Cvilic, Paul Van de Heyning, Diane Van Rompaey, Steven Mariën, Carl Van Laer, Pol Specenier, Johan Allouche, Leen Van den Steen, Laurence Delacroix, Jan B. Vermorken, Jan Vanderwegen, Tatiana Dragan, Gilbert Chantrain, Jean-François Daisne, Georges Lawson, Marc De Bodt, Dirk Van Gestel, S. Beauvois, Olivier M. Vanderveken, Danielle Van den Weyngaert, Gwen Van Nuffelen, Marc Peeters, Gauthier Desuter
Publikováno v:
Head & neck, 41 (7
Head & neck, Vol. 41, no. 7, p. 2197-2207 (2019)
Head and neck: journal for the sciences and specialties of the head and neck
Head & neck, Vol. 41, no. 7, p. 2197-2207 (2019)
Head and neck: journal for the sciences and specialties of the head and neck
Background Radiation-associated-dysphagia is a serious side effect of radiotherapy (RT) for head and neck cancer (HNC). Methods Seventy-six patients had a weekly prospective follow-up from baseline until one week post-RT. Combined mixed model analysi
Autor:
Laurens Carp, Danielle Van den Weyngaert, Eric Van Marck, Jan B. Vermorken, B. Corthouts, Pol Specenier, Olivier M. Vanderveken, Carl Van Laer, Petr Szturz
Publikováno v:
European archives of oto-rhino-laryngology
In recurrent head and neck squamous cell carcinoma ineligible for resection or irradiation, treatment aims primarily at symptom control and quality of life enhancement with an expected outcome of 6-12 months. In 2005, a male patient, born in 1944, wi